Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $609.6300 (2.8%) ($591.3000 - $610.9900) on Wed. Sep. 2, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.12% (three month average) | RSI | 50 | Latest Price | $609.6300(2.8%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | Weekly Trend | REGN declines -0.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(54%) XLV(45%) SPLV(40%) IVW(38%) SPY(38%) | Factors Impacting REGN price | REGN will decline at least -1.06% in a week (0% probabilities). VIXM(-21%) VXX(-7%) UUP(-7%) TBT(-6%) DRIV(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.06% (StdDev 2.12%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $611.45 | 5 Day Moving Average | $608.07(0.26%) | 10 Day Moving Average | $607.87(0.29%) | 20 Day Moving Average | $611.45(-0.3%) | To recent high | -7.3% | To recent low | 3.5% | Market Cap | $64.638b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |